Dr.SportsMedIN said:Quarterly for the first year is convention rather than evidence, and it is defensible for a simple reason: it is roughly the interval over which HbA1c…
That reframing is the part I needed. I will report back once I have actually tried it.
From the other side of the consultation, briefly.
PSA: get baseline labs BEFORE starting baseline bloodwork therapy. You need a "before" picture to measure progress. My recommended pre-treatment panel:
- CMP + A1C + fasting insulin
- Complete lipid panel with particle count if possible
- hsCRP, ferritin, B12, vitamin D
- Thyroid panel (TSH + free T4)
- CBC with differential
- Liver panel (ALT, AST, GGT)
- DEXA scan or body composition
Total cost at Quest without insurance: ~$200. Worth every penny for the data.
Dr.RheumBOS said:Shot day Wednesday report relevant to baseline bloodwork: Week 37.
This is where I part company with the consensus forming above. This treats a plausible mechanism as a demonstrated one. Plausible is where you start looking, not where you stop.
If somebody has the primary source to hand I would rather cite it than paraphrase it.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsAdding the numbers, since they settle part of this. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.
Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here. No action needed from anybody.